Publications by authors named "Frank Tacke"

Claim this Profile
F
From the Editor's Desk..
Philip Newsome, Frank Tacke, Heiner Wedemeyer, Lorenza Rimassa, Annalisa Berzigotti

J Hepatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Trends in Patients Hospitalised With Cirrhosis-Aetiologies, Complications and Outcomes Compared to Other Chronic Health Conditions.
Julian Pohl, Nirbaanjot Walia, Lukas Hofmann, Lena Wolters, Martin Schulz, Frank Tacke

Aliment Pharmacol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries.
Jeffrey V Lazarus, Leire Agirre-Garrido, J Emilio Miralles-Sanchez, Melina I Manolas, Frank Tacke

Liver Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From the Editor's Desk.
Philip Newsome, Frank Tacke, Heiner Wedemeyer, Lorenza Rimassa, Annalisa Berzigotti

J Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic effects of locoregional therapies for unresectable hepatocellular carcinoma.
Robin Schmidt, Bernhard Gebauer, Nilufar Akbari, Christoph Roderburg, Giovanni Federico Torsello, Frank Tacke

JHEP Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dual GLP-1-glucagon agonist pemvidutide in MASH: a phase 2b trial.
Frank Tacke

Lancet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Delphi consensus on surrogate endpoints for treatment assessment in metabolic dysfunction-associated steatohepatitis.
Arun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, Giada Sebastiani, Jörn M Schattenberg, Frank Tacke

Clin Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics of newly diagnosed patients with primary biliary cholangitis (PBC) indicate the need for better awareness on timely diagnosis and adequate UDCA therapy.
Kerstin Stein, Wolf P Hofmann, Annegret Franke, David Petroff, Tobias Müller, Frank Tacke

Z Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: CDK4/6 inhibition enhances T-cell immunotherapy on hepatocellular carcinoma cells by rejuvenating immunogenicity.
Xiurong Cai, Guo Yin, Shuai Chen, Frank Tacke, Adrien Guillot

Cancer Cell Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Extracellular Matrix Biomarkers Illuminate the Architecture of Portal Hypertension in End-Stage Liver Disease.
Igor Spivak, Frank Tacke

Aliment Pharmacol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From the Editor's Desk..
Philip Newsome, Frank Tacke, Heiner Wedemeyer, Lorenza Rimassa, Annalisa Berzigotti

J Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis D.
Toni Herta, Christopher Dietz-Fricke, Münevver Demir, Kathrin Sprinzl, Kai-Henrik Pfeiffer, Frank Tacke

Liver Int· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage Heterogeneity and Plasticity in Liver Injury and Repair Mechanisms.
Tianjiao Zhang, Paul Horn, Moritz Peiseler, Frank Tacke

Stem Cells· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Low-Risk Patients with Cirrhosis and Acute Gastrointestinal Bleeding That May Not Require Urgent Endoscopy.
Sijia Zhang, Mingyu Sun, Shanshan Yuan, Su Lin, Fernando Gomes Romeiro, Frank Tacke

Adv Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of gut-liver-derived mediators on the organ crosstalk with brain, heart, and kidney: A systematic review.
Shruti Bhargava, Zhuangting Rao, Raymond Vanholder, Frank Tacke, Heidi Noels

Mol Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2-F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study.
Vincent Wai-Sun Wong, Neeta B Amin, Hirokazu Takahashi, Amanda Darekar, Frank Tacke

Lancet Gastroenterol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From the Editor's Desk..
Philip Newsome, Frank Tacke, Heiner Wedemeyer, Lorenza Rimassa, Annalisa Berzigotti

J Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first human xenogeneic liver transplantation - A landmark event, but what does it mean for hepatology?
Heiner Wedemeyer, Frank Tacke, Phil Newsome, Vlad Ratziu

J Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pruritus in primary biliary cholangitis: insights from the German PBC registry across secondary and tertiary care.
Toni Herta, Annegret Franke, Tobias Müller, Kerstin Stein, Heike Bantel, Frank Tacke

Ann Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine Countries.
Zobair M Younossi, James M Paik, Jeffrey V Lazarus, Patrizia Burra, Yuichiro Eguchi, Frank Tacke

Clin Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting the immune pathogenesis of HBV-ACLF through single-cell multimodal analysis.
Frank Tacke, Jonel Trebicka

Gut· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage heterogeneity in liver fibrosis.
Wenzhao Wang, Shengwen Li, Yanjun Liu, Xin Ding, Yongqi Yang, Frank Tacke

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Acute pancreatitis: Progress through Restraint?].
Jonathan Frederik Brozat, Frank Tacke

Dtsch Med Wochenschr· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD.
Xiao-Dong Zhou, Li-You Lian, Qin-Fen Chen, Seung Up Kim, Terry Cheuk-Fung Yip, Frank Tacke

J Hepatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning based CAGIB score predicts in-hospital mortality of cirrhotic patients with acute gastrointestinal bleeding.
Zhaohui Bai, Su Lin, Mingyu Sun, Shanshan Yuan, Mariana Barros Marcondes, Frank Tacke

NPJ Digit Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis